Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience.
Journal: Journal of comparative effectiveness research
Published: April 24, 2025
Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access Process.
Journal: Current oncology (Toronto, Ont.)
Published: March 04, 2025
Pharmacological characteristics and clinical outcomes of Epcoritamab (recombinant) (Epkinly® subcutaneous injection ) for malignant lymphoma
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: January 03, 2024
Glofitamab (Columvi) for diffuse large B-cell lymphoma.
Journal: The Medical letter on drugs and therapeutics
Published: July 30, 2023
Epcoritamab-bysp.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: July 20, 2023
Epcoritamab (Epkinly) for diffuse large B-cell lymphoma (DLBCL).
Journal: The Medical letter on drugs and therapeutics
Published: June 20, 2023
Showing 1-9 of 9
Last Updated: 10/31/2025